Aminoglycosides for the treatment of septic shock: a propensity-based study
Open Access
- 21 September 2020
- journal article
- letter
- Published by Springer Nature in Critical Care
- Vol. 24 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimenIntensive Care Medicine, 2014
- Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisCochrane Database of Systematic Reviews, 2014
- Survival in neutropenic patients with severe sepsis or septic shock*Critical Care Medicine, 2012
- Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative MicroorganismsAntimicrobial Agents and Chemotherapy, 2010
- A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression studyCritical Care Medicine, 2010